Cargando…
Illuminating Hope for Mental Health: A Drug Review on Lumateperone
This drug review provides a comprehensive analysis of a novel antipsychotic called lumateperone, marketed as Caplyta. Lumateperone gained FDA approval in 2019 for treating schizophrenia and later, in 2021, for treating bipolar depression. The review begins by delving into lumateperone's mechani...
Autores principales: | Tarzian, Martin, Ndrio, Mariana, Chique, Byron, Serai, Japjit, Thalackal, Bryce, Lau, Jessi, Fakoya, Adegbenro O |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612995/ https://www.ncbi.nlm.nih.gov/pubmed/37900490 http://dx.doi.org/10.7759/cureus.46143 |
Ejemplares similares
-
An Introduction and Brief Overview of Psychoanalysis
por: Tarzian, Martin, et al.
Publicado: (2023) -
Cariprazine for Treating Schizophrenia, Mania, Bipolar Depression, and Unipolar Depression: A Review of Its Efficacy
por: Tarzian, Martin, et al.
Publicado: (2023) -
Lurasidone for Treating Schizophrenia and Bipolar Depression: A Review of Its Efficacy
por: Tarzian, Martin, et al.
Publicado: (2023) -
Facilitating Active Collaborative Learning in Medical Education; a Literature Review of Peer Instruction Method
por: Fakoya, Adegbenro Omotuyi John, et al.
Publicado: (2023) -
The role of lumateperone in the treatment of schizophrenia
por: Syed, Alveena Batool, et al.
Publicado: (2021)